RETREATMENT OF HCV DAA FAILURES: HCV INFECTION MAY BE INCURABLE

被引：4
|
作者：
Hezode, C. [1 ]
Fourati, S. [2 ]
Scoazec, G. [1 ]
Soulier, A. [2 ]
Varaut, A. [1 ]
Francois, M. [1 ]
Ruiz, I. [2 ]
Mallat, A. [1 ]
Chevaliez, S. [2 ]
Pawlotsky., J. -M. [2 ]
机构：
[1] Hop Henri Mondor, Hepatol, Creteil, France
[2] Hop Henri Mondor, Virol, Creteil, France
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00630-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-217
引用
收藏
页码：S400 / S400
页数：1
相关论文
共 50 条
  • [41] PERSISTENCE OF HCV VIREMIA IN CHRONIC HCV INFECTION
    LOK, ASF
    CHEUNG, R
    CHAN, R
    HEPATOLOGY, 1992, 16 (02) : 563 - 563
  • [42] SAMBA II HCV: A new point of care molecular assay for HCV diagnostics and DAA monitoring
    Lee, Helen
    Ritchie, Allyson
    Assennato, Sonny Michael
    Sembongi, Hiroshi
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E499 - E500
  • [43] Peripheral blood cytopenia before treatment in HCV patients: is it a limitation for HCV treatment in the era of DAA?
    Bourliere, Marc
    LIVER INTERNATIONAL, 2012, 32 (07) : 1033 - 1036
  • [44] Quasispecies of HCV is not necessary for emerging resistance-associated substitution of HCV after DAA treatment
    Kai, Yugo
    Hikita, Hayato
    Tatsumi, Tomohide
    Murai, Kazuhiro
    Sakane, Sadatsugu
    Shiode, Yuto
    Nozaki, Yasutoshi
    Makino, Yuki
    Nakabori, Tasuku
    Saito, Yoshinobu
    Tanaka, Satoshi
    Kondo, Yasuteru
    Kato, Takanobu
    Suemizu, Hiroshi
    Sakamori, Ryotaro
    Takehara, Tetsuo
    HEPATOLOGY, 2016, 64 : 103A - 104A
  • [45] Intrahepatic HCV levels in chronic HCV infection
    Bonacini, M
    Redeker, AG
    GUT, 1999, 45 (04) : 630 - 630
  • [46] Efficacy of retreatment of HCV infection after liver transplantation (lt): role of aggressive approach
    Berenguer, Marina
    Vinaixa, Carmen
    Garcia Eliz, Maria
    Alonso, Noelia
    Roche, Bruno
    Navarro Lopez, Laia
    Aguilera, Victoria
    Rubin, Angel
    Duclos-Vallee, Jean-Charles
    Pons, Jose A.
    De la Mata, Manuel
    Prieto, Martin
    Samuel, Didier
    HEPATOLOGY, 2012, 56 : 532A - 532A
  • [47] HCC recurrence after DAA treatment in HCV patients
    Guarino, Maria
    Bruzzese, Dario
    Di Costanzo, Giovan Giuseppe
    Guarracino, Marco
    Morando, Federica
    Sessa, Anna
    Rinaldi, Luca
    Persico, Marcello
    Megna, Angelo Salomone
    Nicola, Coppola
    Cossiga, Valentina
    Caporaso, Nicola
    Morisco, Filomena
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E835 - E836
  • [48] Incidence and Determinants of Denial of DAA Treatment for Chronic HCV Infection by Insurance Type During the First 6 Months of the Modern HCV Treatment Era
    Lo Re, Vincent
    Gowda, Charitha
    Urick, Paul N.
    Halladay, Josh
    Binkley, Amanda
    Carbonari, Dena M.
    Battista, Kathryn
    Peleckis, Cassandra
    Gilmore, Jody
    Roy, Jason
    Reddy, K. Rajender
    Kostman, Jay
    HEPATOLOGY, 2015, 62 (06) : 1382A - 1382A
  • [49] DAA failures in African patients with "unusual'' HCV subtypes: Hey! Didn't you know there was another world?
    Pawlotsky, Jean-Michel
    JOURNAL OF HEPATOLOGY, 2019, 71 (06) : 1070 - 1072
  • [50] HCC RECURRENCE AFTER DAA TREATMENT IN HCV PATIENTS
    Guarino, M.
    Bruzzese, D.
    Di Costanzo, G. G.
    Guarracino, M.
    Morando, F.
    Sessa, A.
    Rinaldi, L.
    Persico, M.
    Megna, A. Salomone
    Coppola, N.
    Caporaso, N.
    Morisco, F.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E95 - E95
12345